Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug-Drug Interactions with Ethionamide Involving Impact of Genetic Polymorphism on FMO3 (cPMTb)

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets (cPMTb)

Effect of rifampin on enantioselective disposition and anti-hypertensive effect of benidipine (cPMTb)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects (cPMTb)

Inhibition of cytochrome P450 activities by Sophora flavescens extract and its prenylated flavonoids in human liver microsomes (cPMTb)

10-Phenyltriazoyl artemisinin is a novel P-glycoprotein inhibitor that suppresses the overexpression and function of P-glycoprotein. (cPMTb)

Genotype-based enrichment study design for minimizing the sample size in bioequivalence study: Tolterodine and CYP2D6 genotype (cPMTb)

What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing. (cPMTb)

Pharmacodynamic effects of voglibose administered alone, administered with metformin and administered with metformin in a fixed-dose combination in healthy Korean subjects (cPMTb)

Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin -Containing Monooxygenase 3 Maturational Changes Over Time (cPMTb)